Depressive Disorder

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Birmingham, Alabama, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Little Rock, Arkansas, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Beverly Hills, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Cerritos, California, United States

• New York State Psychiatric Institute — New York, United States

• Western Psychiatric Institute and Clinica, University of Pittsburgh School of Medicine — Pittsburgh, Pennsylvania, United States

• China Medical University Hospital — Taichung, Taiwan

• Laureate Institute for Brain Research — Tulsa, Oklahoma, United States

• Icahn School of Medicine at Mount Sinai — New York, United States

Not specified

• Primary Care Practices — Hamburg, Germany

• Massachusetts General Hospital — Boston, Massachusetts, United States

• CA004 — Edmonton, Alberta, Canada
• CA005 — Kelowna, British Columbia, Canada
• CA006 — St. John's, Newfoundland and Labrador, Canada
• CA007 — Halifax, Nova Scotia, Canada